您好,欢迎来到科研在线!科研采购 · 选型 · 实验方法
首页产品库品牌馆产品类别品牌新闻会议会展产品试用求职招聘资讯专题教程
PRO / Antibodies

PerCP/Cyanine5.5 Anti-Human HLA-DR Antibody

PerCP/Cyanine5.5 Anti-Human HLA-DR Antibody

英诺赛图(InnoCyto)的 PerCP/Cyanine5.5 Anti-Human HLA-DR Antibody(克隆 L243) 为鼠源 IgG2a 单克隆抗体,靶向 Human,PerCP/Cyanine5.5 标记(488 nm 蓝色激光激发),适用于流式细胞术。提供 25 tests、100 tests 规格,目录价 ¥2,034 起,仅供科研使用(RUO)。

生物试剂 供应商 上海英诺赛图 ↗ 型号 102725 更新 2026-11-12
参考价格区间
¥2,034
含税参考价,实际以配置与渠道报价为准
本条目供应商 上海英诺赛图原厂 1865个条目 进入企业主页

01产品图片

02产品简介

英诺赛图(InnoCyto)的 PerCP/Cyanine5.5 Anti-Human HLA-DR Antibody(克隆 L243) 为鼠源 IgG2a 单克隆抗体,靶向 Human,PerCP/Cyanine5.5 标记(488 nm 蓝色激光激发),适用于流式细胞术。提供 25 tests、100 tests 规格,目录价 ¥2,034 起,仅供科研使用(RUO)。

03产品介绍

规格与货号

102725 | 25 tests | ¥2,034

102726 | 100 tests | ¥4,407

Product Details

Target Name|HLA-DR, Major Histocompatibility Class II, MHC class II

Regulatory Status|RUO

Protein Concentration|Supplied at a lot-specific concentration.

Storage&Handling|The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

Recommended Usage|For flow cytometric staining, it is recommended to use 5 μL of this reagent per 0.5-1.0 million cells in a 100 μL volume. Optimal reagent performance should be determined by titration for each specific application. PerCP/Cyanine5.5 has an excitation max at 482 nm and an emission max at 695 nm.

Price (Converted)|2034

See All Formats|Clone L243

Background Information

HLA-DR is a major histocompatibility complex (MHC) class II molecule that plays a central role in adaptive immune responses by presenting antigenic peptides to CD4⁺ T helper cells. It is primarily expressed on professional antigen-presenting cells (APCs), including dendritic cells, macrophages, B cells, and thymic epithelial cells, and its expression can be induced on other cell types under inflammatory conditions, particularly by interferon-γ.

Structurally, HLA-DR is a heterodimer composed of an α chain (DRA) and a β chain (DRB), each containing two extracellular domains, a transmembrane region, and a short cytoplasmic tail. The α1 and β1 domains together form the peptide-binding groove, which accommodates peptides typically 13–25 amino acids in length. This groove is open at both ends, allowing for flexibility in peptide size. HLA-DR is highly polymorphic, particularly in the DRB genes, enabling the immune system to present a broad repertoire of antigenic peptides derived from pathogens or self-proteins. The ligands of HLA-DR are processed peptide antigens generated from extracellular or vesicular proteins that are internalized, degraded in endosomal compartments, and loaded onto HLA-DR molecules. Peptide loading is tightly regulated by accessory molecules, including the invariant chain (Ii), which prevents premature peptide binding, and HLA-DM, which facilitates peptide exchange and stabilizes high-affinity peptide–HLA-DR complexes. The primary functional interaction of HLA-DR is with the T cell receptor (TCR) on CD4⁺ T cells, initiating T cell activation and differentiation.

HLA-DR is strongly implicated in disease. Specific HLA-DR alleles are associated with susceptibility or protection in numerous autoimmune diseases, including rheumatoid arthritis, type 1 diabetes, systemic lupus erythematosus, and multiple sclerosis, reflecting differences in self-antigen presentation. Aberrant or reduced HLA-DR expression is also observed in cancer and sepsis, where impaired antigen presentation contributes to immune evasion or immunosuppression. Conversely, elevated HLA-DR expression on monocytes is often used as a marker of immune activation and immune competence.

Therapeutically, HLA-DR has both direct and indirect relevance. Anti-HLA-DR monoclonal antibodies have been explored in transplantation and hematologic malignancies to modulate immune responses or deplete malignant APCs. In cancer immunotherapy and vaccine development, effective antigen presentation via HLA-DR is essential for robust CD4⁺ T cell help, supporting durable antitumor and antiviral immunity. Additionally, HLA-DR expression is widely used as a diagnostic and prognostic biomarker in immunology, oncology, and critical care settings.

04完整参数表

参数由厂商资料整理,采购前请以最终报价单与技术协议为准。

包装规格25 tests
CloneL243
ApplicationFlow Cytometry
ReactivityHuman
FormatPerCP/Cyanine5.5
IsotypeMouse IgG2a
Antibody TypeMonoclonal
Regulatory StatusRUO
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and 0.2% (w/v) BSA
Protein ConcentrationSupplied at a lot-specific concentration.
Excitation LaserBlue Laser (488 nm)
Price (Converted)2034
目录价¥2,034

05荣誉与资质

该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。

  • 营业执照未上传
  • 品牌授权未上传
  • 产品检测报告未上传
会员身份
收费会员
经营身份
原厂
成立年份
2020 年
所在地
上海
收录条目
1865 个
平台核验
平台代管
向品牌方索取资质文件

06品牌与供应商

上海英诺赛图 原厂
InnoCyto

以可信赖的细胞研究试剂,助力科研突破

进入企业主页
1865 本目录条目
产地 / 总部上海市浦东新区
成立年份2020 年
本目录主营生化试剂 / 蛋白与抗体

InnoCyto(上海英诺赛图生物科技有限公司)致力于通过开发高质量细胞分析试剂,加速科学发现进程。公司为研究人员提供细胞层面探索所需的工具,推动免疫学、肿瘤学等多领域的研究创新。 核心团队拥有丰富的行业经验,曾参与全球头部生命科学公司的标杆项目搭建,深刻理解工业界与学术研究的前沿需求。试剂从设计之初即以精确性、一致性、高性能为核心标准,让科学家能把精力集中在最核心的研究工作上。 公司将深厚的科学积累与对品质的严格承诺相结合,力争成为全球研究人员信赖的合作伙伴。产品线覆盖经验证的一抗与二抗、同型对照、生物类似药抗体、重组蛋白、细胞因子、免疫检测试剂盒及配套试剂,并提供重组蛋白/抗体表达与标记偶联服务。

售后与服务

品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。

引用此条目 产品目录 · 更新于 2026-11-12
科研在线(TeleVM). PerCP/Cyanine5.5 Anti-Human HLA-DR Antibody(102725)[EB/OL]. 产品目录, 2026-11-12. https://www.suprotek.cn/products/item/percp-cyanine5-5-anti-human-hla-dr-antibody.html.
TeleVM. (2026, November 12). PerCP/Cyanine5.5 Anti-Human HLA-DR Antibody(102725). 产品目录. https://www.suprotek.cn/products/item/percp-cyanine5-5-anti-human-hla-dr-antibody.html
@misc{biocsp_item_percp_cyanine5_5_anti_human_hla_dr_antibody,
  title        = {PerCP/Cyanine5.5 Anti-Human HLA-DR Antibody(102725)},
  author       = {{科研在线}},
  year         = {2026},
  howpublished = {产品目录},
  note         = {更新于 2026-11-12,产品目录},
  url          = {https://www.suprotek.cn/products/item/percp-cyanine5-5-anti-human-hla-dr-antibody.html}
}

GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。

许可:CC BY-NC 4.0 · 转载注明来源
获取正式报价

PerCP/Cyanine5.5 Anti-Human HLA-DR Antibody

提交后由平台转给品牌方,通常 1 个工作日内联系。不需要注册。